|  |  |  |  |  |
| Company | Falcon Pharmaceuticals, Ltd. | Falcon Pharmaceuticals, Ltd. | Falcon Pharmaceuticals, Ltd. | Falcon Pharmaceuticals, Ltd. | Falcon Pharmaceuticals, Ltd. |
| Item | CORTISPORIN* Ophthalmic Suspension | CORTISPORIN* Otic Solution | CORTISPORIN* Otic Suspension | MAXITROL® Ophthalmic Suspension | PRED FORTE* Ophthalmic Suspension |
| Price | Inquire | Inquire | Inquire | Inquire | Inquire |
| Description | Neomycin and Polymyxin B Sulfates and Hydrocortisone ophthalmic suspension is a sterile antimicrobial and anti-inflammatory suspension for ophthalmic use. | Neomycin and Polymyxin B Sulfates and Hydrocortisone otic solution, USP is a sterile antibacterial and anti-inflammatory solution for otic use. | Neomycin and Polymyxin B Sulfates and Hydrocortisone otic suspension, USP is a sterile antibacterial and anti-inflammatory suspension for otic use. | Neomycin and Polymyxin B sulfates and Dexamethasone ophthalmic suspension is a multiple dose anti-infective steroid combination in sterile suspension form for topical applications. | Prednisolone Acetate ophthalmic suspension USP, 1% is an adrenocortical steroid product prepared as a sterile ophthalmic suspension. |
| Approval | USA and Worldwide | USA and Worldwide | USA and Worldwide | USA and Worldwide | USA and Worldwide |
| Type | Suspension | Otic Solution | Otic Suspension | Suspension | Suspension |
| Product Number | 61314-641-75 | 61314-646-10 | 61314-645-10 | 61314-630-06 | 61314-637-15 |
| Size | 7.5 ml | 10 ml | 10 ml | 5 ml | 15 ml |
| Content | Hydrocortisone + Neomycin | Hydrocortisone + Neomycin | Hydrocortisone + Neomycin | Dexamethasone + Neomycin | Prednisolone acetate |
| Strength | Hydrocortisone 1% + Neomycin 3.5 mg | Hydrocortisone 1% + Neomycin 3.5 mg | Hydrocortisone 1% + Neomycin 3.5 mg | Dexamethasone 0.1% + Neomycin 3.5 mg | 1% |
| Supplied as | Drop-Tainer' bottle | Bottle with sterilized dropper | Bottle with sterilized dropper | Plastic 'Drop-Tainer' dispensers | Plastic 'Drop-Tainer' dispensers |
| Get quote | Inquire | Inquire | Inquire | Inquire | Inquire |